The AAD is collaborating with Johnson & Johnson and Kenvue to increase the number of practicing dermatologists who are underrepresented minorities in medicine over the next 5 years through Pathways: ...
Please provide your email address to receive an email when new articles are posted on . This is the third update to the guidelines for treating and managing atopic dermatitis in the last 2 years. The ...
The American Academy of Dermatology (AAD) recently issued a focused update to its guidelines on the management of atopic dermatitis (AD) in adults, strongly recommending four recently approved ...
Through AAD's one-on-one mentorship program, volunteer mentors provide medical students with hands-on exposure in the field of dermatology and help stimulate interest in dermatology as an obtainable ...
A panelist discusses how new data from the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates tildrakizumab’s efficacy in treating nail psoriasis, with the 100-mg dose showing ...
New data analysis on Tirbanibulin shows consistent treatment response for actinic keratosis (AK): data from phase IV and real-world evidence studies show consistently high levels of response as well ...
SCOTCH PLAINS, N.J.--(BUSINESS WIRE)--Navigator Medicines, Inc., a clinical-stage biotech company leading the advancement of biologics for targeted immune regulation and restoration, today announced ...
Christopher J. Sayed, MD, anticipates exciting advancements in hidradenitis suppurativa (HS) at the 2025 American Academy of Dermatology Annual Meeting. With numerous ongoing phase 2 and phase 3 ...
Antonia Haynes is a Game Rant writer who resides in a small seaside town in England where she has lived her whole life. Beginning her video game writing career in 2014, and having an avid love of ...
Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results